Healthy donor cells tested with immune booster N-803
NCT ID NCT06040918
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 25 times
Summary
This early-stage study looked at how a drug called N-803 affects natural killer cells collected from 10 healthy volunteers. The main goal was to check for side effects and see if the drug helps these immune cells grow. It was a small, safety-focused trial with no direct treatment benefit for participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chan Soon-Shiong Institute for Medicine
El Segundo, California, 90245, United States
Conditions
Explore the condition pages connected to this study.